March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get basic information on what safer sex is and is not, how to practice different forms of safer sex, and tips on thinking things through ahead.
Get the information you need when starting treatment – choosing a drug regimen, adherence, resistance, taking your pills, side effects, and more.